首页> Frontiers in oncology> CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified Neuroblastoma.

CAMKV Is a Candidate Immunotherapeutic Target in <i>MYCN</i> Amplified Neuroblastoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Robyn T,Sussman

第一单位： Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States.

作者： Robyn T,Sussman ^[1] ; Jo Lynne,Rokita ^[2] ; Kevin,Huang ^[1] ; Pichai,Raman ^[2] ; Komal S,Rathi ^[2] ; Daniel,Martinez ^[3] ; Kristopher R,Bosse ^[4] ; Maria,Lane ^[1] ; Lori S,Hart ^[1] ; Tricia,Bhatti ^[3] ; Bruce,Pawel ^[5] ; John M,Maris ^[6]

作者单位： Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States. ^[1] Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States.;Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, United States. ^[2] Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, United States. ^[3] Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States.;Department of Pathology, Children's Hospital of Los Angeles, Los Angeles, CA, United States. ^[4] Department of Pathology, Children's Hospital of Los Angeles, Los Angeles, CA, United States. ^[5] Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, United States.;Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA, United States. ^[6]

关键词 CAMKV ChIP-Seq MYCN immunotherapy neuroblastoma

DOI 10.3389/fonc.2020.00302

PMID 32211329

发布时间 2024-03-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交